Korean J Lab Med.  2010 Feb;30(1):9-16. 10.3343/kjlm.2010.30.1.9.

Evaluation of Analytical Measurement Ranges of Three Full Range C-Reactive Protein Tests Using Immunoturbidimetric Assay

• Lee YJ
• Kim JM
• Park DS

• KMID: 1096812
• DOI: http://doi.org/10.3343/kjlm.2010.30.1.9

Abstract

BACKGROUND
Recently developed full-range C-reactive protein (CRP) tests, which are based on the immunoturbidimetric method, have wider analytical measurement ranges (AMR) than previously used tests. We evaluated the AMR of 3 full-range CRP tests-2 new and 1 previously used test.
METHODS
We analyzed the precision and AMR of 2 full-range CRP tests (Sekisui, Nanopia CRP, N-CRP and Iatron, IATRO CRP-EX, I-CRP) and compared the values obtained for these tests with those obtained for the conventional full-range CRP test (Sekisui, PureAuto S CRP, P-CRP). We evaluated the tests for the limit of quantification and for linearity. We also compared these results of these tests by using the comparative test (Dade Behring, cCRP) for cardiovascular risk assessment.
RESULTS
Coefficients of variation (CVs) of all the full-range CRP tests were less than 10% for concentrations greater than 0.6 mg/L, and CVs of N-CRP and I-CRP were lower than those of P-CRP for concentrations less than 1 mg/L. N-CRP (0.1-467 mg/L) and I-CRP (0.1-280 mg/L) had wider AMR than P-CRP (3-233 mg/L). All the full-range CRP tests showed more than 90% agreement with the cCRP values for the assessment of cardiovascular risk.
CONCLUSIONS
The 3 full-range CRP tests, by virtue of their wide AMR, may be used for the detection of acute inflammation as well as for the assessment of cardiovascular risk. N-CRP and I-CRP may be more useful than P-CRP for determining the CRP concentration, especially for the detection of concentrations close to the lower or upper limit of the analytical range, without the need for repetition of the test.

Keyword

C-reactive protein; Analytical measurement range; Cardiovascular risk; Immunoturbidimetry

MeSH Terms

C-Reactive Protein/*analysis
Cardiovascular Diseases/diagnosis
Humans
Immunoassay/*methods
Limit of Detection
Nephelometry and Turbidimetry/*methods
Reproducibility of Results
Risk Assessment